Manufacturing / Pharmaceutical Preparations
Larimar Therapeutics, Inc.
LRMR
$3.01
+$0.32 (+11.85%)
Price as of Nov 13, 2026 22:41 UTC
330 M
Market Cap (Small Cap)
30%
IV Rank
288.6%
Implied Volatility
Mar 17
Next Earnings
Technical Signals
as of Nov 13
Mixed
3 of 7
Trend
- Above 20-day average $2.61
- Above 50-day average $2.88
- Above 200-day average $3.74 · -19.2%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 40d ago
Volume
- Elevated volume 2.0x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.00
Bullish skew
Implied Volatility
288.6%
1% percentile
IV vs Realized
Options rich
30d HV 61.4%
Options Heat Map
Delta-risk grid for LRMR options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
15 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Hamilton Thomas Edward | Buy | 70,000 | $187,082 | +13.0% | |
| Nov 11, 2026 | Celano Michael | Buy | 18,460 | $49,992 | +11.5% | |
| Nov 11, 2026 | BEN-MAIMON CAROLE | Buy | 18,050 | $49,953 | +9.1% | |
| Nov 11, 2026 | Harlow John B. Jr. | Buy | 17,800 | $49,918 | +7.7% | |
| Nov 11, 2026 | THOMAS FRANK E | Buy | 8,000 | $21,800 | +10.8% | |
| Nov 11, 2026 | Shankar Gopi | Buy | 5,000 | $13,549 | +11.4% | |
| Nov 11, 2026 | Truitt Joseph | Buy | 3,500 | $9,792 | +7.9% | |
| Sep 29, 2026 | Harlow John B. Jr. | Grant | 800,000 | $0 | -3.8% | |
| Sep 29, 2026 | Harlow John B. Jr. | Grant | 50,000 | $0 | -3.8% | |
| Jul 06, 2026 | Hamilton Thomas Edward | Buy | 50,000 | $166,890 | -9.5% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Nov 05, 2026 | Q3 2026 | -$0.35 | |||
| Nov 03, 2026 | Q3 2026 | -$0.35 |
Track LRMR with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for LRMR and your entire portfolio.